Summary

Market Size & Trends

The Middle East minimally invasive surgery market size was estimated at USD 7.37 billion in 2024 and is expected to reach USD 13.41 billion by 2033, growing at a CAGR of 7.02% from 2025 to 2033. This growth is driven by the rising prevalence of lifestyle-related diseases, healthcare infrastructure investment, development of medical tourism, increasing adoption of robotic-assisted surgery, and rising demand for bariatric and cosmetic surgery. Countries such as Saudi Arabia, the UAE, and Qatar invest heavily in modern healthcare infrastructure, equipping hospitals with advanced robotic systems and laparoscopic platforms to attract medical tourism and reduce patient outflow abroad. In addition, the region’s young but increasingly urbanized population is contributing to higher demand for elective surgeries, including bariatric and cosmetic procedures, many of which are performed using minimally invasive surgery (MIS) methods.

The minimally invasive surgery (MIS) market in Middle East is expanding steadily, supported by government-led healthcare reforms, rising rates of lifestyle-related diseases, and growing investments in advanced surgical infrastructure. Countries such as Saudi Arabia and the UAE are at the forefront, driven by national health strategies such as Saudi Vision 2030 and the UAE’s Centennial 2071 plan, which emphasize modernizing healthcare delivery and increasing access to advanced technologies. High prevalence of obesity and diabetes in the region is also fueling demand for bariatric and metabolic surgeries, many of which are now performed using laparoscopic and robotic-assisted techniques to minimize recovery times and complications.

In recent years, hospitals in the GCC have also adopted robotic surgery platforms and AI-enabled imaging systems across specialties, including gynecology, cardiothoracic surgery, and bariatrics. In Saudi Arabia, several hospitals have introduced robotic-assisted programs for bariatric and urological procedures. At the same time, the UAE has witnessed rapid uptake of laparoscopic and endoscopic interventions across its major healthcare hubs such as Dubai and Abu Dhabi. In 2023, Saudi surgeons performed landmark robotic heart and liver transplant surgeries-highlighting the region’s growing expertise in complex minimally invasive interventions and positioning the Middle East as an emerging hub for advanced surgical care.

Despite these advances, challenges remain, including shortages of highly trained MIS surgeons and uneven access to advanced facilities outside major urban centers. Governments and healthcare providers are pursuing initiatives such as cross-border collaborations, partnerships with academic institutions, and expansion of training programs for laparoscopic and robotic techniques to bridge this gap. The increasing role of private healthcare providers and the growth of medical tourism, especially in the UAE, are also expected to play a pivotal role in boosting the availability and adoption of MIS across the region in the coming years.

In 2024, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia marked global milestones with the world’s first fully robotic heart transplant performed on a 16-year-old patient, followed by the first robotic-assisted implantation of an artificial heart pump. These achievements underscore the country's leadership in high-complexity MIS and reflect the broader push under Vision 2030 toward medical innovation and specialized surgical care. Further building on this momentum, in July 2025, KFSHRC executed the world’s first robotic-assisted BiVAD (biventricular assist device) implantation, using minimally invasive robotic arms to support a patient with advanced heart failure.

At the same time, neurological innovation is also gaining ground in the region. Cleveland Clinic Abu Dhabi recently became the first in the Middle East and North Africa to use the Artisse Intrasaccular Flow Modulator, a minimally invasive device for treating wide-necked brain aneurysms - a less invasive alternative to traditional open neurosurgery.

Middle East Minimally Invasive Surgery Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East minimally invasive surgery (MIS) market report based on surgical specialty, method, end-use, and country:

• Surgical Specialty Outlook (Revenue, USD Million, 2021 - 2033)
• General Surgery
• Gastrointestinal Surgery
• Gynecological Surgery
• Urological Surgery
• Cardiothoracic Surgery
• Orthopedic & Spine Surgery
• Neurosurgery
• Colorectal Surgery
• Bariatric Surgery
• Vascular & Endoscopic Surgery
• Plastic & Reconstructive Surgery
• Method Outlook (Revenue, USD Million, 2021 - 2033)
• Laparoscopic Surgery
• Thoracoscopic Surgery/VATS
• Robotic-assisted Surgery
• Endoscopic Surgery
• Catheter-based/Interventional Procedures
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others
• Country Outlook (Revenue, USD Million, 2021 - 2033)
• Middle East
o Saudi Arabia
o UAE
o Kuwait
o Qatar
o Oman
o Rest of Middle East

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1. Segment Definitions
1.1.1. Surgical Specialty
1.1.2. Method
1.1.3. End Use
1.1.4. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Surgical Specialty outlook
2.2.2. Method outlook
2.2.3. End Use outlook
2.3. Competitive Insights
Chapter 3. Middle East Minimally Invasive Surgery (MIS) Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising surgical volumes
3.2.1.2. Technological advancements in surgical robotics & imaging
3.2.1.3. Growing medical tourism
3.2.2. Market Restraint Analysis
3.2.2.1. High capital and procedure costs
3.2.2.2. Complex training requirements
3.3. Minimally Invasive Surgery (MIS) Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.4. Minimally Invasive Surgery (MIS) Market: Number of Procedures
3.5. Minimally Invasive Surgery (MIS) Market: Average Procedure Pricing
Chapter 4. Middle East Minimally Invasive Surgery (MIS) Market: Surgical Specialty Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Minimally Invasive Surgery (MIS) Market: Surgical Specialty Movement Analysis
4.3. Minimally Invasive Surgery (MIS) Market by Surgical Specialty Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. General Surgery
4.5.1. General Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Gastrointestinal Surgery
4.6.1. Gastrointestinal Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Urological Surgery
4.7.1. Urological Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Cardiothoracic Surgery
4.8.1. Cardiothoracic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9. Orthopedic & Spine Surgery
4.9.1. Orthopedic & Spine Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.10. Neurosurgery
4.10.1. Neurosurgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11. Colorectal Surgery
4.11.1. Colorectal Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.12. Bariatric Surgery
4.12.1. Bariatric Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.13. Vascular & Endovascular Surgery
4.13.1. Vascular & Endovascular Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.14. Plastic & Reconstructive Surgery
4.14.1. Plastic & Reconstructive Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Minimally Invasive Surgery (MIS) Market: Method Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Minimally Invasive Surgery (MIS) Market: Method Movement Analysis
5.3. Minimally Invasive Surgery (MIS) Market by Method Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Laparoscopic Surgery
5.5.1. Laparoscopic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Thoracoscopic Surgery/VATS
5.6.1. Thoracoscopic Surgery/VATS Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Robotic-assisted Surgery
5.7.1. Robotic-assisted Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Endoscopic Surgery
5.8.1. Endoscopic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Catheter-based/Interventional Procedures
5.9.1. Catheter-based/Interventional Procedures Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.10. Others
5.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Minimally Invasive Surgery (MIS) Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Minimally Invasive Surgery (MIS) Market: End Use Movement Analysis
6.3. Minimally Invasive Surgery (MIS) Market by End Use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Ambulatory Surgical Centers (ASCs)
6.6.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Specialty Clinics
6.7.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Others
6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Others
6.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East Minimally Invasive Surgery Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Middle East Minimally Invasive Surgery Market movement analysis
7.3. Middle East Minimally Invasive Surgery Market: Regional Estimates & Trend Analysis by Product & Application
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.4.1. Middle East
7.4.1.1. Middle East Minimally Invasive Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.1.1.1. Qatar
7.4.1.1.1.1. Key Country Dynamics
7.4.1.1.1.2. Competitive Scenario
7.4.1.1.1.3. Regulatory Framework
7.4.1.1.1.4. Reimbursement scenario
7.4.1.1.1.5. Qatar Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.1.1.2. Oman
7.4.1.1.2.1. Key Country Dynamics
7.4.1.1.2.2. Competitive Scenario
7.4.1.1.2.3. Regulatory Framework
7.4.1.1.2.4. Reimbursement scenario
7.4.1.1.2.5. Oman Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.1.1.3. Saudi Arabia
7.4.1.1.3.1. Key Country Dynamics
7.4.1.1.3.2. Competitive Scenario
7.4.1.1.3.3. Regulatory Framework
7.4.1.1.3.4. Reimbursement scenario
7.4.1.1.3.5. Saudi Arabia Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.1.1.4. UAE
7.4.1.1.4.1. Key Country Dynamics
7.4.1.1.4.2. Competitive Scenario
7.4.1.1.4.3. Regulatory Framework
7.4.1.1.4.4. Reimbursement scenario
7.4.1.1.4.5. UAE Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.1.1.5. Kuwait
7.4.1.1.5.1. Key Country Dynamics
7.4.1.1.5.2. Competitive Scenario
7.4.1.1.5.3. Regulatory Framework
7.4.1.1.5.4. Reimbursement scenario
7.4.1.1.5.5. Kuwait Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.1.1.6. Turkey
7.4.1.1.6.1. Key Country Dynamics
7.4.1.1.6.2. Competitive Scenario
7.4.1.1.6.3. Regulatory Framework
7.4.1.1.6.4. Reimbursement scenario
7.4.1.1.6.5. Turkey Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Medtronic plc
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Intuitive Surgical
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. CMR Surgical
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Smith & Nephew plc
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Renishaw
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Robotics Surgical Systems (UAE)
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Auris Health
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Olympus Corporation
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Siemens Healthineers
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Corindus Vascular Robotics
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Middle East Minimally Invasive Surgery Market by Country, 2021 - 2033 (USD Million)
Table 4 Middle East Minimally Invasive Surgery (MIS) market, by surgical specialty, 2021 - 2033 (USD Million)
Table 5 Middle East Minimally Invasive Surgery (MIS) market, by method, 2021 - 2033 (USD Million)
Table 6 Middle East Minimally Invasive Surgery (MIS) market, by End Use, 2021 - 2033 (USD Million)
Table 7 Qatar Minimally Invasive Surgery Market by Surgical Specialty, 2021 - 2033 (USD Million)
Table 8 Qatar Minimally Invasive Surgery Market by Method, 2021 - 2033 (USD Million)
Table 9 Oman Minimally Invasive Surgery Market by Surgical Specialty, 2021 - 2033 (USD Million)
Table 10 Oman Minimally Invasive Surgery Market by Method, 2021 - 2033 (USD Million)
Table 11 Saudi Arabia Minimally Invasive Surgery Market by Surgical Specialty, 2021 - 2033 (USD Million)
Table 12 Saudi Arabia Minimally Invasive Surgery Market by Method, 2021 - 2033 (USD Million)
Table 13 UAE Minimally Invasive Surgery Market by Surgical Specialty, 2021 - 2033 (USD Million)
Table 14 UAE Minimally Invasive Surgery Market by Method, 2021 - 2033 (USD Million)
Table 15 Kuwait Minimally Invasive Surgery Market by Surgical Specialty, 2021 - 2033 (USD Million)
Table 16 Kuwait Minimally Invasive Surgery Market by Method, 2021 - 2033 (USD Million)List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 MIDDLE EAST Minimally Invasive Surgery (MIS): market outlook
Fig. 9 MIDDLE EAST Minimally Invasive Surgery (MIS) market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Middle East Minimally Invasive Surgery (MIS) market driver impact
Fig. 15 Middle East Minimally Invasive Surgery (MIS) market restraint impact
Fig. 16 Middle East Minimally Invasive Surgery (MIS) market strategic initiatives analysis
Fig. 17 Middle East Minimally Invasive Surgery (MIS) market: surgical specialty movement analysis
Fig. 18 Middle East Minimally Invasive Surgery (MIS) market: surgical specialty outlook and key takeaways
Fig. 19 General surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Gastrointestinal surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Gynecological surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Urological surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Cardiothoracic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Orthopedic & spine surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Neurosurgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Colorectal surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Bariatric surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Vascular & endovascular surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Plastic & reconstructive surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Middle East Minimally Invasive Surgery (MIS) market: method movement analysis
Fig. 31 Middle East Minimally Invasive Surgery (MIS) market: method outlook and key takeaways
Fig. 32 Laparoscopic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Thoracoscopic surgery/VATS market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Robotic-assisted surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Endoscopic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Catheter-based interventional procedures market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Minimally Invasive Surgery (MIS) market, end-use outlook key takeaways (USD Million)
Fig. 39 Minimally Invasive Surgery (MIS) market end-use movement analysis 2024 & 2033 (USD Million)
Fig. 40 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Participant categorization- Middle East Minimally Invasive Surgery (MIS) market
Fig. 45 Market share of key market players- Middle East Minimally Invasive Surgery (MIS) market